Difference between revisions of "CSCR-051 Add Material.expirationTime"
RikSmithies (talk | contribs) |
|||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 12: | Line 12: | ||
== Issue == | == Issue == | ||
| − | Material.expirationTime is used in UK models. Use case is the expiration date of the material (instance). | + | Material.expirationTime is used in UK models. Use case is the expiration date of the material (instance) (see also CSCR-052). |
== Recommendation == | == Recommendation == | ||
| Line 18: | Line 18: | ||
== Rationale == | == Rationale == | ||
| + | Required for when dispensed material instances are to be carried. | ||
== Discussion == | == Discussion == | ||
| Line 26: | Line 27: | ||
== Resolution == | == Resolution == | ||
| + | 2 March 2006 | ||
| + | Motion: Applicable to manufactured material that includes material and labeled drug classes (IDLTS) and 0…1 optional | ||
| + | 1st PL 2nd PM-J. Accept proposal. Against 0 Abstain 0 For 8 . Approved. | ||
| + | |||
| + | Hans Buitendijk, Isobel Frean, Andrew Perry, Rik Smithies; Patrick Mitchell-Jones, Austin Kreisler Heath Frankel, Patrick Lloyd | ||
| + | |||
| + | 20 April 2006 | ||
| + | CSP v0.2.3 updated - CVB | ||
Latest revision as of 14:58, 20 April 2006
Editing of Change Requests is restricted to the submitter and the co-chairs of the Clinical Statement Project. Other changes will be undone. Please add comments to the "discussion" page associated with this Change Request.
Back to Clinical Statement Change Requests page.
| Submitted by: Rik Smithies | Revision date: 12-Feb-2006 |
| Submitted date: 12-Feb-2006 | Change request ID: CSCR-051 |
Issue
Material.expirationTime is used in UK models. Use case is the expiration date of the material (instance) (see also CSCR-052).
Recommendation
- Add Material.expirationTime
Rationale
Required for when dispensed material instances are to be carried.
Discussion
Recommended Action Items
Resolution
2 March 2006 Motion: Applicable to manufactured material that includes material and labeled drug classes (IDLTS) and 0…1 optional 1st PL 2nd PM-J. Accept proposal. Against 0 Abstain 0 For 8 . Approved.
Hans Buitendijk, Isobel Frean, Andrew Perry, Rik Smithies; Patrick Mitchell-Jones, Austin Kreisler Heath Frankel, Patrick Lloyd
20 April 2006 CSP v0.2.3 updated - CVB
